Mutual of America Capital Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,664
| Closed | -$213K | – | 1397 |
|
|
2025
Q1 | $213K | Sell |
9,664
-389
| -4% | -$9.15K | ﹤0.01% | 1332 |
|
|
2024
Q4 | $228K | Buy |
10,053
+18
| +0.2% | +$393 | ﹤0.01% | 1347 |
|
|
2024
Q3 | $182K | Sell |
10,035
-1,233
| -11% | -$28.6K | ﹤0.01% | 1406 |
|
|
2024
Q2 | $328K | Sell |
11,268
-29,258
| -72% | -$868K | ﹤0.01% | 1260 |
|
|
2024
Q1 | $1.44M | Sell |
40,526
-1,553
| -4% | -$62.1K | 0.02% | 991 |
|
|
2023
Q4 | $1.83M | Sell |
42,079
-3,974
| -9% | -$156K | 0.02% | 930 |
|
|
2023
Q3 | $1.76M | Sell |
46,053
-5,746
| -11% | -$242K | 0.02% | 920 |
|
|
2023
Q2 | $2.13M | Sell |
51,799
-6,648
| -11% | -$320K | 0.02% | 884 |
|
|
2023
Q1 | $3.36M | Sell |
58,447
-1,224
| -2% | -$69K | 0.04% | 690 |
|
|
2022
Q4 | $3.35M | Buy |
59,671
+1,323
| +2% | +$67.3K | 0.04% | 669 |
|
|
2022
Q3 | $2.47M | Sell |
58,348
-1,452
| -2% | -$74.4K | 0.03% | 747 |
|
|
2022
Q2 | $3.23M | Sell |
59,800
-6,625
| -10% | -$398K | 0.04% | 657 |
|
|
2022
Q1 | $4.27M | Buy |
66,425
+1,277
| +2% | +$84.1K | 0.05% | 620 |
|
|
2021
Q4 | $4.36M | Buy |
65,148
+1,039
| +2% | +$70.3K | 0.04% | 637 |
|
|
2021
Q3 | $4.39M | Buy |
64,109
+1,540
| +2% | +$109K | 0.04% | 599 |
|
|
2021
Q2 | $4.27M | Sell |
62,569
-1,365
| -2% | -$96.5K | 0.04% | 620 |
|
|
2021
Q1 | $4.42M | Sell |
63,934
-2,046
| -3% | -$139K | 0.05% | 589 |
|
|
2020
Q4 | $4.28M | Sell |
65,980
-219
| -0.3% | -$11.8K | 0.05% | 544 |
|
|
2020
Q3 | $3.13M | Buy |
66,199
+1,531
| +2% | +$72.8K | 0.04% | 605 |
|
|
2020
Q2 | $3.04M | Sell |
64,668
-1,711
| -3% | -$84.1K | 0.04% | 605 |
|
|
2020
Q1 | $2.96M | Buy |
66,379
+2,395
| +4% | +$126K | 0.05% | 506 |
|
|
2019
Q4 | $3.73M | Buy |
63,984
+540
| +0.9% | +$32.1K | 0.05% | 592 |
|
|
2019
Q3 | $3.81M | Buy |
63,444
+510
| +0.8% | +$30.4K | 0.05% | 543 |
|
|
2019
Q2 | $3.51M | Buy |
62,934
+400
| +0.6% | +$20.6K | 0.05% | 586 |
|
|
2019
Q1 | $3.48M | Sell |
62,534
-152
| -0.2% | -$7.74K | 0.05% | 582 |
|
|
2018
Q4 | $2.83M | Buy |
62,686
+2,690
| +4% | +$148K | 0.05% | 625 |
|
|
2018
Q3 | $3.95M | Sell |
59,996
-381
| -0.6% | -$23.7K | 0.06% | 535 |
|
|
2018
Q2 | $3.89M | Buy |
+60,377
| New | +$3.74M | 0.06% | 536 |
|
|
2017
Q1 | – | Sell |
-53,746
| Closed | -$2.31M | – | 1218 |
|
|
2016
Q4 | $2.31M | Buy |
53,746
+19,746
| +58% | +$803K | 0.04% | 711 |
|
|
2016
Q3 | $1.4M | Hold |
34,000
| – | – | 0.03% | 901 |
|
|
2016
Q2 | $1.36M | Buy |
+34,000
| New | +$1.22M | 0.03% | 892 |
|
Other funds holding IART
RCMNY
PCMI
Mutual of America Capital Management's IART Position: Q2 2025 in Review
Mutual of America Capital Management sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 9,664 shares — an estimated $213K sold.
Mutual of America Capital Management first reported a position in IART in Q2 2016 and held it in 31 quarters. The position peaked at $4.42M in Q1 2021. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.
- Mutual of America Capital Management reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
- Mutual of America Capital Management sold 9,664 Integra LifeSciences shares in Q2 2025, an estimated $213K.
- Mutual of America Capital Management first reported a position in Integra LifeSciences in Q2 2016 and held it in 31 quarters.
- Mutual of America Capital Management's Integra LifeSciences position peaked at $4.42M in Q1 2021.
- 208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.
Based on Mutual of America Capital Management's 13F filing for Q2 2025, filed 29 Jul 2025.